| 1 |
33803289 | Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection. | 2021 Mar 9 |
1 |
| 2 |
33922540 | Therapeutic Value of Single Nucleotide Polymorphisms on the Efficacy of New Therapies in Patients with Multiple Sclerosis. | 2021 Apr 23 |
2 |
| 3 |
34426902 | Dimethyl fumarate prevents cytotoxicity and apoptosis mediated by oxidative stress in human adipose-derived mesenchymal stem cells. | 2021 Sep |
1 |
| 4 |
29928650 | The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis. | 2018 Jun |
2 |
| 5 |
28156185 | Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. | 2017 Dec |
3 |
| 6 |
25009787 | Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms. | 2014 |
5 |
| 7 |
24076006 | Effects of fumaric acid esters on blood-brain barrier tight junction proteins. | 2013 Oct 25 |
2 |
| 8 |
15655414 | Enhanced cytotoxicity of bioreductive antitumor agents with dimethyl fumarate in human glioblastoma cells. | 2005 Feb |
1 |
| 9 |
15877230 | Effect of NQO1 induction on the antitumor activity of RH1 in human tumors in vitro and in vivo. | 2005 Sep |
1 |
| 10 |
15467770 | Dietary induction of NQO1 increases the antitumour activity of mitomycin C in human colon tumours in vivo. | 2004 Oct 18 |
2 |
| 11 |
10376975 | Enhanced cytotoxicity of mitomycin C in human tumour cells with inducers of DT-diaphorase. | 1999 Jun |
1 |